Infantile hypertrophic pyloric stenosis in infants treated with azithromycin

Pediatr Infect Dis J. 2007 Feb;26(2):186-8. doi: 10.1097/01.inf.0000253063.87338.60.

Abstract

Seven-week-old 32-week premature triplets were hospitalized because of rhinorrhea, cough with color change and posttussive emesis. One infant had a positive direct fluorescent antibody test for Bordetella pertussis, so all were treated with 5 days of azithromycin. Two of the infants were subsequently diagnosed with hypertrophic pyloric stenosis and underwent surgical pyloromyotomies 6 and 7 weeks, respectively, after the initial admission.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Azithromycin / adverse effects*
  • Azithromycin / therapeutic use
  • Bordetella pertussis / isolation & purification
  • Cough
  • Cyanosis
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature, Diseases* / chemically induced
  • Infant, Premature, Diseases* / drug therapy
  • Pyloric Stenosis, Hypertrophic / chemically induced*
  • Pyloric Stenosis, Hypertrophic / diagnosis
  • Pyloric Stenosis, Hypertrophic / surgery
  • Rhinitis
  • Triplets*
  • Vomiting
  • Whooping Cough / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Azithromycin